REMUS PHARMACEUTICALS L

REMUS

Small Cap | Pharmaceuticals
₹629.95
+4.95 (+0.79%)

Stock price as on 02 Apr 2026 at 10:43 AM

Remus pharmaceuticals l share price update

As of the latest trading session, Remus Pharmaceuticals L share price is currently at ₹629.95, which is up by ₹4.95 from its previous closing. Today t...

Remus Pharmaceuticals L stock performance

Today’s low

₹600

Today’s high

₹648

₹629.95

52 week low

₹580

52 week high

₹1,145

₹629.95
Open
₹648.00
Previous close
₹625.00
Share volume
1,900
Total traded value (Lakh)
₹13.20
Upper circuit
₹750.00
Lower circuit
₹500.00

Remus Pharmaceuticals L fundamentals

Market cap (Cr)
₹819.00
P/E ratio (TTM)
40.76
Book value per share
₹205.55
Beta
0.86
Return on equity
10.06%
Earnings per share (TTM)
₹16.76
Dividend yield
0.22%
Net profit/quarter (Cr)
₹0.00

Remus Pharmaceuticals L technical summary

₹695
+ 0.94 ▲
3
Bearish
13
Bullish
5 Day650
10 Day641.5
12 Day641.9
20 Day647.7
26 Day652.5
50 Day669.6
100 Day706
200 Day778.7
5 Day639.5
10 Day621.5
12 Day628.6
20 Day651
26 Day660.6
50 Day674.6
100 Day694.8
200 Day792

681.17

PIVOT

First support
₹617.33
First resistance
₹752.33
Second support
₹546.17
Second resistance
₹816.17
Third support
₹482.33
Third resistance
₹887.33
RSI
56.98
ADX
15.35
MACD
-10.54
Williams % R
-34.24
Commodity Channel Index (CCI)
62.57
Date
16 Mar 2026
Same day
9,200
Week
4,983
Month
3,247
1 year
0.87
3 years
0.99
Over 1 month
5.33%
Over 1 year
-30.96%
Over 3 months
-6.19%
Over 3 years
45.26%
Over 6 months
-15.96%
Over 6 years
0%

Investment Returns

Over 1 Month5.33%
Over 3 Months6.19%
Over 6 Months15.96%
Over 1 Year30.96%

Remus Pharmaceuticals L Shareholding pattern


Public
24.07%
Promoter holdings
70.9%
FII
5.01%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Shah Arpit Deepakkumar

20,80,000 (17.65%)

Shareholding of Promoter and Promoter Group

Roma Vinodbhai Shah

20,27,800 (17.21%)

Shareholding of Promoter and Promoter Group

Swapnil Jatinbhai Shah

20,00,000 (16.97%)

Shareholding of Promoter and Promoter Group

Anar Swapnil Shah

20,00,000 (16.97%)

Shareholding of Promoter and Promoter Group

India Emerging Giants Fund Limited

5,60,500 (4.76%)

Public Shareholding

Promoter sharesShareCategory
Shah Arpit Deepakkumar20,80,000 (17.65%)Shareholding of Promoter and Promoter Group
Roma Vinodbhai Shah20,27,800 (17.21%)Shareholding of Promoter and Promoter Group
Swapnil Jatinbhai Shah20,00,000 (16.97%)Shareholding of Promoter and Promoter Group
Anar Swapnil Shah20,00,000 (16.97%)Shareholding of Promoter and Promoter Group
India Emerging Giants Fund Limited5,60,500 (4.76%)Public Shareholding
Rekha Gunavanth Kumar1,28,000 (1.09%)Public Shareholding
Hemant Ishwarlal Modi1,17,600 (1%)Shareholding of Promoter and Promoter Group
Renosen Pharmaceuticals Private Limited1,07,800 (0.91%)Shareholding of Promoter and Promoter Group
Sonal Hemantbhai Modi8,000 (0.07%)Shareholding of Promoter and Promoter Group
Mansi Aadarsh Shah8,000 (0.07%)Shareholding of Promoter and Promoter Group
Vinodkumar Gandalal Shah6,300 (0.05%)Shareholding of Promoter and Promoter Group
Dhruvalben Vishal Shah200 (0%)Shareholding of Promoter and Promoter Group

About REMUS PHARMACEUTICALS L

Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat. Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. It de

Parent Organisation

Indian Private

NSE Symbol

REMUS

Founded

2015

REMUS PHARMACEUTICALS L CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
14 Nov 20250.5Interim 114 Nov 2025Equity shares
18 Sept 20250.5Final18 Sept 2025Equity shares
19 Nov 20241Interim20 Nov 2024Equity shares
02 May 20244Interim 202 May 2024Equity shares
27 Oct 20232Interim28 Oct 2023Equity shares
15 Sept 20232Final15 Sept 2023Equity shares

View more stocks

What’s trending

All stocks

FRONTFN

FRONTLINE FINANCIAL SERVICES L

2.25
+0.75 (+50%)
MOIL

MOIL LIMITED

297.65
+49.6 (+20%)
MPEL

MANAS POLYMER N ENERGIE L

50.4
+8.4 (+20%)
GOKULAGRO

GOKUL AGRO RESOURCES LTD

191
+31.83 (+20%)
View all

Top gainers

HCLTECH

HCL TECHNOLOGIES LTD

1402.2
+47.80 (+3.53%)
TECHM

TECH MAHINDRA LIMITED

1441.5
+37.00 (+2.63%)
INFY

INFOSYS LIMITED

1300.8
+25.10 (+1.97%)
WIPRO

WIPRO LTD

194.91
+3.73 (+1.95%)
View all

Top losers

EICHERMOT

EICHER MOTORS LTD

6649.5
-176.00 (-2.58%)
ASIANPAINT

ASIAN PAINTS LIMITED

2169
-56.80 (-2.55%)
ETERNAL

ETERNAL LIMITED

231.72
-4.80 (-2.03%)
SUNPHARMA

SUN PHARMACEUTICAL IND L

1693.6
-34.90 (-2.02%)
View all

Frequently asked questions



Related tags


You are here


Related links


Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

Powered by Bajaj Financial Securities Limited (Bajaj Broking)